Vanta Bioscience Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
as on 14-12-2024
- Paid Up Capital ₹ 6.31 Cr
as on 14-12-2024
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.33 Cr
as on 14-12-2024
- Satisfied Charges ₹ 17.00 Cr
as on 14-12-2024
- Revenue -39.10%
(FY 2023)
- Profit -5495.65%
(FY 2023)
- Ebitda -113.98%
(FY 2023)
- Net Worth -17.70%
(FY 2023)
- Total Assets 2.46%
(FY 2023)
About Vanta Bioscience
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 540729.
The Corporate was formerly known as Vanta Bioscience Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 6.31 Cr.
The company currently has active open charges totaling ₹19.33 Cr. The company has closed loans amounting to ₹17.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Vanta Bioscience Limited India are Venkata Dokka as Cfo, Sangeetha Choudhary as Company Secretary, and Vidisha Hingu as Company Secretary. Yogeswara Danda, Dopesh Mulakala, Padmanabhuni Appaji, and Two other members serve as directors at the Company.
- CIN/LLPIN
L74999TG2016PLC109280
- Company No.
109280
- Stock Symbol
BSE : 540729
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
29 Apr 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Vanta Bioscience Limited offer?
Vanta Bioscience Limited offers a wide range of products and services, including Material Testing Labs & Services, Laboratory Testing Services, Testing Services.
Who are the key members and board of directors at Vanta Bioscience?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dopesh Mulakala  | Managing Director | 29-Apr-2016 | Current |
| Venkata Dokka | CFO | 11-Nov-2021 | Current |
| Sangeetha Choudhary | Company Secretary | 02-May-2024 | Current |
| Vidisha Hingu | Company Secretary | 15-Sep-2022 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Yogeswara Danda | Director | 22-May-2019 | Current |
| Padmanabhuni Appaji | Director | 20-Mar-2017 | Current |
| Vyasmurti Shingatgeri | Whole-Time Director | 08-Feb-2017 | Current |
| Gonuguntla Kathyayani | Director | 19-May-2017 | Current |
Financial Performance and Corporate Structure Insights of Vanta Bioscience.
Vanta Bioscience Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 39.1% decrease. The company also saw a substantial fall in profitability, with a 5495.65% decrease in profit. The company's net worth observed a substantial decline by a decrease of 17.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vanta Bioscience?
In 2023, Vanta Bioscience had a promoter holding of 69.36% and a public holding of 30.65%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sai Med Pharma Systems Private LimitedActive 29 years 11 monthsPadmanabhuni Appaji is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 27 Mar 2017 | ₹19.33 Cr | Open |
Axis Bank Limited Creation Date: 03 Dec 2019 | ₹17.00 Cr | Satisfied |
How Many Employees Work at Vanta Bioscience?
Vanta Bioscience has a workforce of 43 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vanta Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vanta Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
